Page last updated: 2024-12-05

2-nitropyrene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2-Nitropyrene is a potent mutagen and suspected human carcinogen found in various environmental sources. It is formed during incomplete combustion processes, such as those occurring in coal-fired power plants, diesel engines, and cigarette smoke. Synthesis of 2-nitropyrene involves the nitration of pyrene, typically with nitric acid in the presence of a catalyst. Its mutagenic effects are attributed to its ability to form DNA adducts, leading to mutations and potential cancer development. Research on 2-nitropyrene focuses on understanding its formation pathways, environmental fate, and toxicological effects to develop strategies for mitigating its exposure and associated health risks. It is studied due to its widespread presence in the environment and its potential to contribute to human health problems.'

Cross-References

ID SourceID
PubMed CID13090
CHEMBL ID354722
CHEBI ID82506
SCHEMBL ID10788183
MeSH IDM0140728

Synonyms (18)

Synonym
pyrene, 2-nitro-
2-nitropyrene
ccris 3374
brn 2126122
chebi:82506 ,
2-nitro-pyrene
CHEMBL354722
789-07-1
C19476
unii-gi0f8r15cu
gi0f8r15cu ,
AKOS015905447
DTXSID30229368
SCHEMBL10788183
MAZCGYFIOOIVHE-UHFFFAOYSA-N
Q27156013
nitropyrene, 2-
2-nitropyrene [iarc]
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pyrenes
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID200690Mutagenic activity in an Ames test on Salmonella Typhimurium TA98; Activity is log of revertants/nmol1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID23442Partition coefficient (logP)1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (9.52)18.7374
1990's10 (47.62)18.2507
2000's2 (9.52)29.6817
2010's6 (28.57)24.3611
2020's1 (4.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.47 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index5.65 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (8.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (91.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]